← Back to Patent Explorer
US4013688A Expired / Lapsed US ⏱️ 0.0 years remaining

Radioimmunoassay agents

Assignee: Pharmacia and Upjohn Co
•
Filing: 1972-12-20
•
Granted: 1977-03-22
•
Expires: 1992-12-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel steroid derivatives containing a tyrosine ester amide group linked to an 11-hydroxysteroid alkylene dicarboxylic hemi-ester are described, suitable for iodination with radioactive iodine, useful in radioimmunoassay.

Inventors

  • 👤 John C. Babcock
  • 👤 J. Allan Campbell

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 18:52
CPC Classifications
C; C07; C07J; C07J41/00; C07J41/0033; C07J41/0094; C07J1/00; C07J1/0003; C07J1/0011; C07J1/0018; C07J1/0022; C07J1/0033; C07J1/0037; C07J1/0051; C07J1/0059; C07J1/0066; C07J1/007; C07J41/005; C07J41/0072; C07J5/00; C07J5/0007; C07J5/0015; C07J53/00; C07J7/00; C07J7/0005; C07J7/001; C07J7/0015; C07J7/002; C07J7/004; C07J7/0045; C07J7/0065; C07J7/007

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 69 words
A compound having the following structural formula ##STR15## wherein St is a steroid moiety linked through the 11-carbon atom and selected from the group consisting of those moieties corresponding to 2α -hydroxypregn-4-en-3-one 20β-hydroxypregn-4-en-3-one 17α-hydroxypregn-4-ene-3,20-dione 21-hydroxypregn-4-ene-3,20-dione 17α,21-dihydroxypregn-4-ene-3,20-dione 17β-hydroxyandrost-4-en-3-one (testosterone) 17β-hydroxy-5α-androstan-3-one 17β-hydroxy-5β-androstan-3-one 5α-androstane-3β,17β-diol 17β-hydroxyestr-4-en-3-one (19-nortestosterone) estrone estradiol estriol estr-5-ene-3β,17β-diol androst-5-ene-3β,17β-diol dehydroepiandrosterone pregnenolone 21-hydroxypregnenolone 17α-hydroxypregnenolone 17,21-dihydroxypregnenolone 17β,17α-dimethyl-17-hydroxyandrost-4-en-3-one, and R is a lower alkyl group containing from 1 to 6 carbon atoms inclusive.
Claim 2
Dependent Claim 69 words
A compound having the following structural formula ##STR15## wherein St is a steroid moiety linked through the 11-carbon atom and selected from the group consisting of those moieties corresponding to 2α -hydroxypregn-4-en-3-one 20β-hydroxypregn-4-en-3-one 17α-hydroxypregn-4-ene-3,20-dione 21-hydroxypregn-4-ene-3,20-dione 17α,21-dihydroxypregn-4-ene-3,20-dione 17β-hydroxyandrost-4-en-3-one (testosterone) 17β-hydroxy-5α-androstan-3-one 17β-hydroxy-5β-androstan-3-one 5α-androstane-3β,17β-diol 17β-hydroxyestr-4-en-3-one (19-nortestosterone) estrone estradiol estriol estr-5-ene-3β,17β-diol androst-5-ene-3β,17β-diol dehydroepiandrosterone pregnenolone 21-hydroxypregnenolone 17α-hydroxypregnenolone 17,21-dihydroxypregnenolone 17β,17α-dimethyl-17-hydroxyandrost-4-en-3-one, and R is a lower alkyl group containing from 1 to 6 carbon atoms inclusive.

References Cited (Backward Citations)

US2666070A Cited
US2698331A Cited
US3055921A Cited
US3086033A Cited
US3225034A Cited
US3178457A Cited
US3462423A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-03-21 1980-09-20 1981-03-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-03-21 1984-09-20 1985-03-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-03-21 1988-09-20 1989-03-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag